BUSINESS COMBINATION (Details Textual) (USD $)	3 Months Ended	9 Months Ended			3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2014	Jun. 19, 2013	Sep. 30, 2013 Selling, General and Administrative Expenses [Member]	Sep. 30, 2013 Selling, General and Administrative Expenses [Member]	Sep. 30, 2013 Interest Expense [Member]	Sep. 30, 2013 Other Expense [Member]	Sep. 30, 2014 Teva License Intangible Asset [Member]	Jun. 19, 2013 BioSante Pharmaceuticals Inc [Member]	Jun. 19, 2013 ANIP Acquisition Company [Member]
Business Acquisition, Percentage of Voting Interests Acquired										43.00%	57.00%
Share Price				$ 1.22
Finite-Lived Intangible Asset, Useful Life									11 years
Business Combination Deferred Tax Assets Established Gross			$ 9,600,000
Business Combination Deferred Tax Liabilities Established Gross			3,900,000
Valuation allowance			5,700,000
Business Combination, Acquisition Related Costs	500,000	6,200,000			500,000	5,500,000	300,000	400,000
Business Combination Purchase Price Allocation Deferred Tax Assets, Net			$ 0